dalteparin has been researched along with Hepatocellular Carcinoma in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grieco, A | 1 |
| Lombardo, A | 1 |
| Biolato, M | 1 |
| Sengodan, P | 1 |
| Grewal, H | 1 |
| Gandhi, S | 1 |
| Negm, O | 1 |
| Abou Saif, S | 1 |
| El Gharib, M | 1 |
| Yousef, M | 1 |
| Abd-Elsalam, S | 1 |
1 trial available for dalteparin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma.
Topics: Adult; Aged; Anticoagulants; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Egypt; Enoxa | 2017 |
2 other studies available for dalteparin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Carcinoma, Hepatocellular; Enoxaparin; Heart Diseases; | 2013 |
Invasive hepatocellular carcinoma with recurrent pulmonary embolism: use of AngioVac cannula thrombectomy device for mechanical aspiration.
Topics: Adult; Angiography; Anticoagulants; Antineoplastic Agents; Carcinoma, Hepatocellular; Enoxaparin; Fa | 2014 |